BRIC Hernia Repair Devices Market Outlook to 2023 Global Glaucoma Market by Value, Segments, Drug Cl

Global Glaucoma Market by Value, Segments, Drug Class, Region,
Analysis and Forecast to 2021
ReportsWeb.com published “Glaucoma Market” from its database. The report covers the market
landscape and its growth prospects over the coming years. The report also includes a discussion
of the key vendors operating in this market.
Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss.
The most common type is open-angle glaucoma with less common types including closed-angle
glaucoma and normal-tension glaucoma. Open-angle glaucoma develops slowly over time and
there is no pain. Side vision may begin to decrease followed by central vision resulting in
blindness, if not treated. Closed-angle glaucoma can present gradually or suddenly. The sudden
presentation may involve severe eye pain, blurred vision, mid-dilated pupil, redness of the eye,
and nausea. Vision loss from glaucoma, once it has occurred, is permanent.
Though, glaucoma cannot be cured completely but the disease progression can be controlled
with the help of available treatments. There are three types of modalities available for
treatment of glaucoma: Drugs, Laser and Invasive Surgery. Further, based upon the approaches
employed for the medication, it can be segmented into two parts: PGA Medication and Non-
PGA Medication. The PGA approach reduces IOP with the help of prostaglandin (PGA). The non-
PGA medication can be further divided into four sub segments: Beta blockers, Alpha blockers,
Carbonic anhydrase inhibitors (CAIs) and Combination Products.
For more information about this report: http://www.reportsweb.com/global-glaucoma-
market-industry-analysis-and-outlook
Several factors such as rising prevalence of diabetes, growing geriatric population and rising
health care expenditure along with increasing disposable income and growing obese population
will drive the market growth in the next few years. Development of new drugs & devices and
drug therapy focused upon IOP are the few notable market trends. However, high cost of
treatment, severe side effects and hasty drug approval processes act as a major roadblock for
the market growth.
The report "Global Glaucoma Market: Industry Analysis & Outlook (2017-2021)" analyzes the
development of this market, with focus on the US and OUS treatment market. The major
trends, growth drivers as well as issues being faced by the market are discussed in detail in this
report. The four major players: Pfizer Inc., Novartis AG, Merck & Co., Inc. and Allergan Plc. are